Pancreatic tumors in multiple endocrine neoplasia type 1: Clinical presentation and surgical treatment
Authors:
- 1 July 1992
- journal article
- Published by Wiley in World Journal of Surgery
- Vol. 16 (4) , 611-618
Abstract
Among 33 patients with endocrine pancreatic tumors due to multiple endocrine neoplasia type 1 (MEN‐1), 19 (58%) patients had hypergastrinemia, 7 (21%) patients had hyperinsulinism, and 7 (21%) patients had clinically non‐functioning lesions. At least one gross tumor was found in all patients undergoing pancreatic surgery, including those with negative localization studies prior to operation. The patients also had additional macroscopic tumors as well as numerous microadenomas, and the lesions frequently were positive for immunostaining with multiple hormones, mainly pancreatic polypeptide, insulin, glucagon, and somatostatin. Duodenal endocrine lesions were found in 4 of 5 investigated patients and stained with gastrin and somatostatin antibodies. Distal, mainly subtotal pancreatic resection, was performed in 18 patients, eventually combined with caput tumor enucleation or duodenotomy, while a few patients underwent only tumor enucleation or a Whipple procedure. The long‐erm outcome of operation was most favorable in patients with hyperinsulinism; only 1 patient had clinical recurrence. Patients with hypergastrinemia experienced only transitory lowering of serum gastrin values after pancreatic surgery and 47% of them had or developed metastases. Such tumor spread was seen in 57% of the patients with non‐functioning lesions. Nine patients died from progressive tumor disease during follow‐up. Consistent with previous studies, we found that surgery is indicated in MEN‐1 patients with hyperinsulinism even if a lesion is not visualized by radiology. In addition, these indications should be extended to also include patients with only biochemical markers of disease, including elevations of gastrin, as these indicate the presence of gross tumors. This strategy should be applied especially in patients with aggressive family histories to possibly reduce the risk of malignant tumor progression.Keywords
This publication has 29 references indexed in Scilit:
- Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromesWorld Journal of Surgery, 1992
- Gastrinomas in the Duodenums of Patients with Multiple Endocrine Neoplasia Type 1 and the Zollinger-Ellison SyndromeNew England Journal of Medicine, 1990
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinomaNature, 1988
- Intraoperative Ultrasonographic Localization of Islet Cell TumorsAnnals of Surgery, 1988
- Total pancreatectomy in the MEN-1 syndromeBritish Journal of Surgery, 1988
- Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patientsCancer, 1986
- Treatment of the Zollinger-Ellison syndromeThe American Journal of Surgery, 1982
- Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathiesThe American Journal of Surgery, 1980
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971